Persistence on F/TAF versus F/TDF for HIV Pre-Exposure Prophylaxis: A Real-World Evidence Analysis in the United States

HIV Prevention Summit 2021

Community PrEP Service delivery for Female Sex Workers in Ghana

HIV Prevention Summit 2021

Socio-demographics of individuals initiated on HIV pre-exposure prophylaxis (PrEP) in Nigeria

HIV Prevention Summit 2021

Uptake of HIV post-exposure prophylaxis, completion rates and self-reported reasons for non-completion among health care workers at Mbarara Regional Referral Hospital

HIV Prevention Summit 2021

Characterizing Non-Occupational Post Exposure Prophylaxis for HIV in 5 Urban Health Centers of Kampala, Uganda: January 2016 - June 2019

HIV Prevention Summit 2021

Intimate partner violence and gender-based violence among people living with HIV in southern Nigeria

HIV Prevention Summit 2021

Post-Exposure Prophylaxis, Post-Violence Care and Ongoing HIV Risk: Missed Opportunities for HIV Prevention through Pre-Exposure Prophylaxis and Other Interventions

HIV Prevention Summit 2021

Assessing Knowledge About Pre-exposure Prophylaxis at a Higher Education Institution in The Western Cape, South Africa Using Limited Episodes of The MTV Shuga Series

HIV Prevention Summit 2021

Development and implementation of a pre-exposure prophylaxis (PrEP) curriculum for pediatric residents

HIV Prevention Summit 2021

Increasing visibility, uptake and retention of Pre-Exposure Prophylaxis (PrEP) users among men who have sex with men (MSM) in Nairobi, Kenya through let’s Get Real Events (LGR).

HIV Prevention Summit 2021

Understanding barriers to HIV Pre-Exposure Prophylaxis scale up in Lusaka urban.

HIV Prevention Summit 2021

Burden of HIV infection among the elderly in urban Ethiopia

HIV Prevention Summit 2021

The Covid-19 pandemic and its effect on the sex market in Mexico City

HIV Prevention Summit 2021

Perceptions of the Effectiveness of Health Education Strategies in Reducing Harm from HIV in Libyan Married Women

HIV Prevention Summit 2021

Virological Failures and Genotypic Resistance in Children and Adolescents Randomised to Dolutegravir-Based ART vs. Standard-of-Care in the ODYSSEY Trial

International Workshop on HIV Pediatrics 2021

Early Infant Diagnosis of HIV and Linkage to Antiretroviral Therapy in the Context of COVID-19 in Fifteen Sub-Saharan African Countries

International Workshop on HIV Pediatrics 2021

Pediatric and Adolescent HIV Viral Load Coverage and Suppression Rates in the Context of the COVID-19 Pandemic in 14 Sub-Saharan African PEPFAR Countries in 2019 and 2020

International Workshop on HIV Pediatrics 2021

Efficacy, Safety and Tolerability of Guideline-Recommended ARVs from Pediatric Clinical Trials: A Systematic Review

International Workshop on HIV Pediatrics 2021

Once-Daily Integrase Inhibitor (Insti) With Boosted Darunavir is Non-Inferior to Standard of Care in Virogically Suppressed Children, Week 48 Results of the Smile PENTA-17 Trial

International Workshop on HIV Pediatrics 2021

B/F/Taf in Virologically Suppressed Adolescents and Children: Two-Year Outcomes in 6 to <18 Year Olds And Six-Month Outcomes in Toddlers

International Workshop on HIV Pediatrics 2021

Long-term Safety & Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fumarate (E/C/F/TAF) Single-Tablet Regimen in in Children and Adolescents Living with HIV

International Workshop on HIV Pediatrics 2021

Pharmacokinetics and Safety of Dispersible- and Immediate-Release FDC Dolutegravir/Abacavir/Lamivudine in Children with HIV Weighing ≥14 kg: Preliminary Results from IMPAACT 2019

International Workshop on HIV Pediatrics 2021

Pharmacokinetics, Safety and Acceptability of a Single Dose of Abacavir/Lamivudine/Lopinavir/Ritonavir (4-In-1) Fixed-Dose Granule Formulation In Neonates: PETITE Study

International Workshop on HIV Pediatrics 2021

Clinical Impact and Cost-Effectiveness of Viral Load Testing (VLT) to Inform the Transition to Pediatric Dolutegravir (DTG) in Antiretroviral Therapy (ART)-Experienced Children With HIV in South Africa

International Workshop on HIV Pediatrics 2021